China-based Cloopen Group avoids fine in SEC accounting fraud case
By 
Kyle Brasseur2024-02-07T12:51:00
A China-based technology company won’t pay a fine in settling with the Securities and Exchange Commission (SEC) over an alleged accounting fraud scheme perpetrated by two of its former senior managers.
Cloopen Group Holding, a provider of cloud communications products and services, dodged a potential penalty from the SEC for violations that included running afoul of reporting, recordkeeping, and internal control provisions of the federal securities laws, the agency announced Tuesday.
In October, Cloopen announced it received its final delisting determination from the New York Stock Exchange (NYSE) after failing to timely file certain of its annual reports for years impacted by the alleged fraud scheme.
Related articles
-
PremiumChinese regulators impose six-month ban, $62M fine on PwC’s China unit
Chinese authorities banned PwC’s Chinese unit from performing audits in the country for six months, labeling the subsidiary’s flawed audit work as complicit in the failure of giant property developer Evergrande.
-
News BriefCircor avoids fine after self-reporting accounting control violations to SEC
Massachusetts-based technology company Circor International settled charges with the Securities and Exchange Commission regarding deficient internal accounting controls without paying a fine.
-
News BriefDOJ orders Evoqua to pay $8.5M over admitted securities fraud
Evoqua Water Technologies agreed to pay $8.5 million as part of a nonprosecution agreement with the Department of Justice to settle admitted criminal charges related to fraudulent revenue recognition.
More from Regulatory Enforcement
-
News BriefFTC complaint accuses LA Fitness parent companies of blocking easy membership exits
The Federal Trade Commission filed a complaint against LA Fitness’ parent companies, citing difficulties canceling memberships, a month after a court blocked the agency’s click-to-cancel rule.
-
ArticleJudge orders CVS to pay nearly $290M for Medicare false claims
CVS’s Caremark division knowingly overcharged Medicare for prescription drugs and must pay nearly $290 million, a Pennsylvania federal judge has ordered.
-
News BriefSEC charges duo in $275 million water vending machine Ponzi scheme
The owner of a water machine vending company and a portfolio manager were allegedly behind a Ponzi-like scheme that raised more than $275 million, according to the U.S. Securities and Exchange Commission.